LEADER 01123nam2 2200385 450 001 990001360470203316 005 20040121164628.0 035 $a000136047 035 $aUSA01000136047 035 $a(ALEPH)000136047USA01 035 $a000136047 100 $a20040121g1973----km-y0itay0103----ba 101 0 $afre 102 $aFR 105 $a||||||||001yy 200 1 $a<<8.>> : Lettre d'un député de Picardie$fpar Babeuf 210 $aParis$cMicroeditions Hachette$d1973 215 $a1 microfot., 8 p.$d10x15 cm 300 $aMicroriproduzione. - Ed. orig.: [S.l. : S.n.], 1790 410 0$12001 454 1$12001 461 1$1001000136018$12001$aBabeuf et le Babouvisme 600 1 $aBabeuf,$bGracchus 606 0 $aFrancia$xStoria$zSec. 18. 676 $a848 702 1$aSOBOUL,$bA. 801 0$aIT$bsalbc$gISBD 912 $a990001360470203316 951 $a848 BAB Microfot.$b15212 L.M.$c848 959 $aBK 969 $aUMA 979 $aSIAV5$b10$c20040121$lUSA01$h1646 979 $aPATRY$b90$c20040406$lUSA01$h1736 996 $aLettre d'un député de Picardie$9932474 997 $aUNISA LEADER 02999nam 2200673 a 450 001 9910778257103321 005 20231206203647.0 010 $a0-19-773027-2 010 $a0-19-020764-7 010 $a1-4356-0960-3 010 $a1-281-37477-6 010 $a9786611374778 010 $a0-19-804331-7 010 $a0-19-804332-5 010 $a1-4356-1761-4 035 $a(CKB)1000000000480301 035 $a(EBL)415247 035 $a(OCoLC)476241217 035 $a(SSID)ssj0000141640 035 $a(PQKBManifestationID)11163234 035 $a(PQKBTitleCode)TC0000141640 035 $a(PQKBWorkID)10090233 035 $a(PQKB)10853530 035 $a(Au-PeEL)EBL415247 035 $a(CaPaEBR)ebr10199669 035 $a(CaONFJC)MIL137477 035 $a(Au-PeEL)EBL7035855 035 $a(MiAaPQ)EBC415247 035 $a(EXLCZ)991000000000480301 100 $a20070108d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDrugs and justice$b[electronic resource] $eseeking a consistent, coherent, comprehensive view /$fMargaret P. Battin ... [et al.] ; with additional contributions from David G. Dick ... [et al.] 210 $aOxford ;$aNew York $cOxford University Press$d2008 215 $a1 online resource (308 p.) 300 $aDescription based upon print version of record. 311 $a0-19-532100-6 311 $a0-19-532101-4 320 $aIncludes bibliographical references and index. 327 $aDrugs "across the board" -- How did it come to be this way? -- Drug regulatory agencies and the underlying rationales for drug policy -- Core conceptual problems : addiction -- Core conceptual problems : harm (and benefit) -- Dilemmas of drug management and control -- Toward justice in drug theory, policy, and practice. 330 $aThis compact and innovative book tackles one of the central issues in drug policy: the lack of a coherent conceptual structure for thinking about drugs. Drugs generally fall into one of seven categories: prescription, over the counter, alternative medicine, common-use drugs like alcohol, tobacco and caffeine; religious-use, sports enhancement; and of course illegal street drugs like cocaine and marijuana. Our thinking and policies varies wildly from one to the other, with inconsistencies that derive more from cultural and social values than from medical or scientific facts. Penalties exist for 606 $aDrug control$zUnited States 606 $aDrug abuse$xGovernment policy$zUnited States 606 $aDrugs$xLaw and legislation$zUnited States 615 0$aDrug control 615 0$aDrug abuse$xGovernment policy 615 0$aDrugs$xLaw and legislation 676 $a364.1/770973 701 $aBattin$b M. Pabst$01469588 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910778257103321 996 $aDrugs and justice$93860350 997 $aUNINA